Industry Overview - The cannabis sector has experienced significant volatility and downtrends, making it challenging for investors to achieve decent returns [1][2] - Despite these challenges, the cannabis industry is progressing and remains profitable, with growing markets in Europe, Canada, and parts of South America [2][3] - Recent trading indicates a potential resurgence in the cannabis sector, driven by ongoing federal reform efforts in the USA [3] Company Highlights - Cronos Group Inc.: Engages in the cultivation, production, distribution, and marketing of cannabis products internationally. Reported Q2 2025 earnings on August 7 [4] - SNDL Inc.: Focuses on the production, distribution, and sale of cannabis products for the adult-use market in Canada. Announced its 2025 Annual and Special Meeting of Shareholders at the end of July [5][7] - Aurora Cannabis Inc.: Involved in the production, distribution, and sale of cannabis and cannabis-derivative products globally. Recently launched an English-language version of the Physician Experience Platform in collaboration with Copeia [8][9] Financial Performance - SNDL Inc.: Reported net revenue of $33.5 million in Q2 2025, an increase of $5.7 million from Q2 2024. Gross profit was $14.5 million, up by $8.2 million from the previous year. However, net loss increased to $38.5 million, up by $29.7 million from Q2 2024. Adjusted EBITDA improved to $1.7 million, a $12.7 million increase from Q2 2024 [6]
3 Marijuana Stocks For Better Gains This Month